For one Mazda CX-90 owner, however, the promise of a plug-in hybrid unraveled just two days after she drove the car home.

LeBoutheller took his car to a different Toyota dealer, where technicians found aluminum particles in the fluid and indicated ...

If you are interested in adding a classic car to your collection, there are several options, but here are five from the '80s ...

Nearly every home and business in Pepperell, Massachusetts, lost power Tuesday morning. Nearly 5,000 customers, approximately 95% of the town, lost power, according to the Massachusetts Emergency ...

You know that gut drop when your car starts to sound or feel off. Maybe it's a strange shudder, a delayed shift, or that dreaded warning light on the dash. You take it to the shop, hoping it's just a ...

For years, automakers were reliant on 6-speed transmissions. However, they began to adopt 8-speed replacements, following pressure from the government to meet new environmental regulations. When the 8 ...

LG’s OLED TVs are some of our favorites, making this a deal worth jumping on. LG’s OLED TVs are some of our favorites, making this a deal worth jumping on. No matter which version you choose, both TVs ...

The LG C4 OLED is one of the best TVs we've ever tested, offering incredible picture performance and great features at a lower price than flagship models. If you want the 65-inch C4, it got a great ...

The healthcare company is an obvious buy, at least according to one analyst tracking its fortunes. After all, he just modified his recommendation from the equivalent of hold to buy. That morning ...

Passionate mental health providers are fed up after multiple paychecks were delivered late, and they say it feels like déjà vu on top of it. CBS News Chicago has covered financial problems at the very ...

This article is part of Gizmodo Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Reading time 2 minutes Prime Day is here and that ...

CCCC's valuation is unjustifiably low, trading at half its liquidity despite a promising pipeline and no imminent cash crisis. Lead candidate cemsidomide shows encouraging early efficacy and ...